Get started
Author

D. K. Novik

Observed names: Dmitry Novik, Dzmitry Novik, Novik, Dmitry, Д. К. Новик, Д.К. Новик
ORCID: 0000-0001-5278-5557
Observed ORCID: 0000-0001-5278-5557
OpenAlex ID: A5000304422
Evaluation of haplotype callers for next-generation sequencing of viruses
2020 · Anton Eliseev, Keylie M. Gibson, et al. · Infection Genetics and Evolution · 47
PDF
von Willebrand factor/factor VIII concentrate (Wilate) prophylaxis in children and adults with von Willebrand disease
2024 · Robert F. Sidonio, Ana Boban, et al. · Blood Advances · 27
PDF
The incidence of Ph-negative chronic myeloproliferative neoplasms in Belarus
2023 · V. N. Martinkov, D. K. Novik, et al. · Гематология и трансфузиология · 4
PDF
Polymerase Chain Reaction for Prognosis Assessment and Monitoring of the Epstein-Barr Virus-Associated Hodgkin’s Lymphoma
2018 · M. A. Katin, Ivan Viktorovich Zhil’tsov, et al. · Clinical oncohematology · 2
PDF
Results of a Double-Blind Prospective Comparative Randomized Phase 3 Clinical Trial of the Efficacy and Safety of BCD-264 and Darzalex as Monotherapy for Relapsed/Refractory Multiple Myeloma (BCD-264-2/DARVIVA)
2026 · T. V. Shelekhova, J. Kumar, et al. · Clinical oncohematology · 1
PDF
Sustainable development as a management guideline: a view from Russia
2026 · Novik, Dmitry · Revista Cubana de Administración Pública y Empresarial
Efficacy and Safety of Prophylaxis With a Plasma‐Derived von Willebrand Factor/Factor VIII Concentrate (Wilate) in Patients With Type 3 von Willebrand Disease—A WIL‐31 Study Sub‐Analysis
2026 · Claudia Djambas Khayat, Leonid Dubey, et al. · European Journal Of Haematology
Risk factors for thrombotic complications in patients with Polycythemia Vera
2025 · V. N. Martinkov, D. K. Novik, et al. · Medical and Biological Problems of Life Activity
PDF
Association between serum C-reactive protein levels and clinical and laboratory characteristics of patients with polycythemia vera
2025 · V. N. Martinkov, D. K. Novik, et al. · Medical and Biological Problems of Life Activity
PDF
P1658: Clinical Characteristics of a High-positive Antiphospholipid Syndrome
2023 · Sviatlana Khoduleva, Igor Stoma, et al. · HemaSphere
Efficacy and Safety of Prophylaxis with a Plasma-Derived Von Willebrand Factor/ Factor VIII Concentrate in Previously Treated Patients with Von Willebrand Disease
2022 · Robert F. Sidonio, Jr., Ana Boban, et al. · Blood
The Incidence of Ph-negative Chronic Myeloproliferative Diseases in the Population of the Gomel Region of the Republic of Belarus
2021 · Д.К. Новик, В.Н. Мартинков, et al. · Гематология Трансфузиология Восточная Европа
PDF
Молекулярно-генетическая И Клинико-лабораторная Характеристика Пациентов С Ph-негативными Хроническим И Миелопролифетаривными Заболеваниями
2019 · А. Е. Силин, Д. К. Новик, et al. · Вестник гематологии
Прогностическое значение молекулярно-генетических маркеров при остром миелобластном лейкозе
2015 · Ж. М. Козич, Д. К. Новик, et al. · Медицинские новости
Assessment of Effectiveness of Fludarabine-containing Chemotherapy Programs in Oncohematological Patients
2014 · D. V. Kravchenko, D. K. Novik · Health and Ecology Issues
PDF
THE Analysis of CEBPA, NPM1, FLT3 and P53 gene mutations in groups of patients with myelodysplastic syndrome and acute nonlymphocytic leukaemia
2013 · A. E. Silin, V. N. Martinkov, et al. · Health and Ecology Issues
PDF
Condition of Secondary Hemostasis in Children With Purpura Rheumatica
2010 · S. A. Hoduleva, I. P. Romashevskaya, et al. · Health and Ecology Issues
PDF
Клинико-морфологическая характеристика лимфомы Ходжкина у детей
2010 · С. А. Ходулева, И. П. Ромашевская, et al.
Works count: 18
Citation count: 81
H-index: 3
I10-index: 2
Year
Topic
Type